moxifloxacin has been researched along with Chlamydia pneumoniae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazama, I; Nakajima, T | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
2 other study(ies) available for moxifloxacin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
Dual infection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in patients with atopic predispositions successfully treated by moxifloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Dermatitis, Atopic; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pneumonia, Mycoplasma; Remission Induction; Young Adult | 2014 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |